Search Results

search

Search Filters

Tag
Psilocybin
PharmAla Biotech Logo 800 x 422.png
PharmAla Contracts with Partner to Act as US Distributor
March 24, 2025 09:00 ET | PharmAla Biotech
PharmAla sidesteps tariff risk and expands clinical operations in the United States by contracting with Sharp Clinical Services as distribution partner
PharmAla Biotech Logo 800 x 422.png
PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands
March 10, 2025 09:24 ET | PharmAla Biotech
PharmAla opens the European Market for MDMA, signs Duchefa Farma as its first national-level distributor for LaNeo MDMA in Europe
Primary black.png
Psychedelic Science 2025 Announces Select Speakers for the Leading Conference on Psychedelic Research, Policy, and Thought Leadership
March 07, 2025 12:40 ET | Psychedelic Science 2025
Former U.S. Sen. Kyrsten Sinema, Former Ohio Rep. Tim Ryan, Dr. Bessel van der Kolk, Harriet de Wit, Ph.D, Paul Stamets, and other policymakers, researchers, Veterans, therapists, and thought leaders...
PharmAla Biotech Logo 800 x 422.png
PharmAla Completes Shipment of LaNeo™ MDMA to UCLA for Schizophrenia Study
March 03, 2025 09:01 ET | PharmAla Biotech
PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial
Primary black.png
CALLING ALL PODCASTERS: Psychedelic Science 2025 Unveils Dedicated Podcast Studio, Expanding the Dialogue in Psychedelic Research and Education
February 13, 2025 09:00 ET | Psychedelic Science 2025
The first-ever dedicated podcast recording area at a Psychedelic Science conference offers podcasters a prime location to capture conversations with scientists, policymakers, and industry leaders...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Announces Search for New Executive Director as it Doubles Down on Advocacy and Movement Building MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...
PharmAla Biotech Logo 800 x 422.png
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
February 06, 2025 16:06 ET | PharmAla Biotech
PharmAla adds Matthew Azrieli to Advisory Team
PharmAla Biotech Logo 800 x 422.png
PharmAla Issues Q1 Financial Statements
January 29, 2025 16:10 ET | PharmAla Biotech
PharmAla releases its Q1 financial statements
PharmAla Biotech Logo 800 x 422.png
PharmAla Issues Audited Financial Statements, Completes Continuance to Ontario, and Closes Private Placement
December 20, 2024 16:55 ET | PharmAla Biotech
PharmAla files audited financials for year ended August 31, 2024, completes continuance and oversubscribed private placement
PharmAla Biotech Logo 800 x 422.png
PharmAla Announces Private Placement
December 13, 2024 09:25 ET | PharmAla Biotech
PharmAla announces private placement financing